(2018) Adalimumab/immunosuppressants/infliximab. Reactions Weekly, 1732 (1) 23 doi:10.1007/s40278-018-55479-8
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Adalimumab/immunosuppressants/infliximab | ||
Journal | Reactions Weekly | ||
Year | 2018 (December) | Volume | 1732 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-018-55479-8Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13376987 | Long-form Identifier | mindat:1:5:13376987:8 |
GUID | 0 | ||
Full Reference | (2018) Adalimumab/immunosuppressants/infliximab. Reactions Weekly, 1732 (1) 23 doi:10.1007/s40278-018-55479-8 | ||
Plain Text | (2018) Adalimumab/immunosuppressants/infliximab. Reactions Weekly, 1732 (1) 23 doi:10.1007/s40278-018-55479-8 | ||
In | (2018, December) Reactions Weekly Vol. 1732 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |